Fecal HMGB1 reveals microscopic inflammation in adult and pediatric patients with inflammatory bowel disease in clinical and endoscopic remission, Palone, Francesca, Vitali Roberta, Cucchiara S., Mennini M., Armuzzi A., Pugliese D., D'incà R., Barberio B., and Stronati L. , Inflammatory Bowel Diseases, Volume 22, Number 12, p.2886-2893, (2016)

Dipotassium glycyrrhizate via HMGB1 or AMPK signaling suppresses oxidative stress during intestinal inflammation, Vitali, Roberta, Palone Francesca, Pierdomenico Maria, Negroni Anna, Cucchiara S., Aloi M., Oliva S., and Stronati L. , Biochemical Pharmacology, Volume 97, Number 3, p.292-299, (2015)

Endoplasmic reticulum stress and unfolded protein response are involved in paediatric inflammatory bowel disease, Negroni, Anna, Prete E., Vitali Roberta, Cesi Vincenzo, Aloi M., Civitelli F., Cucchiara S., and Stronati L. , Digestive and Liver Disease, Volume 46, Number 9, p.788-794, (2014)

Necroptosis is active in children with inflammatory bowel disease and contributes to heighten intestinal inflammation, Pierdomenico, Maria, Negroni Anna, Stronati L., Vitali Roberta, Prete E., Bertin J., Gough P.J., Aloi M., and Cucchiara S. , American Journal of Gastroenterology, Volume 109, Number 2, p.279-287, (2014)

Plasma high mobility group box 1 protein reflects fibrosis in pediatric nonalcoholic fatty liver disease, Alisi, A., Nobili V., Ceccarelli S., Panera N., De Stefanis C., De Vito R., Vitali Roberta, Bedogni G., Balsano C., Cucchiara S., et al. , Expert Review of Molecular Diagnostics, Volume 14, Number 6, p.763-771, (2014)

Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease, Palone, Francesca, Vitali Roberta, Cucchiara S., Pierdomenico Maria, Negroni Anna, Aloi M., Nuti F., Felice C., Armuzzi A., and Stronati L. , Inflammatory Bowel Diseases, Volume 20, Number 8, p.1448-1457, (2014)

Tu1622 Glycyrrhizin Decreases HMGB1 Release and Is Effective for the Treatment of Chemical-Induced Murine Colitis, Vitali, Roberta, Palone Francesca, Negroni Anna, Costanzo Manuela, Dilillo Anna, Aloi Marina, D'Arcangelo Giulia, Cucchiara Salvatore, and Stronati Laura , Gastroenterology, Volume 5, Number 144, p.S–808, (2013)

Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease, Negroni, Anna, Costanzo Manuela, Vitali Roberta, Superti F., Bertuccini L., Tinari A., Minelli F., Di Nardo G., Nuti F., Pierdomenico Maria, et al. , Inflammatory Bowel Diseases, Volume 18, Number 5, p.913-924, (2012)

Fecal HMGB1 is a novel marker of intestinal mucosal inflammation in pediatric inflammatory bowel disease, Vitali, Roberta, Stronati L., Negroni Anna, Di Nardo G., Pierdomenico Maria, Del Giudice E., Rossi P., and Cucchiara S. , American Journal of Gastroenterology, Volume 106, Number 11, p.2029-2040, (2011)

The nuclear protein HMGB1 is increased in the stools of IBD patients and appears to be a novel marker of intestinal inflammation, Stronati, Laura, Vitali Roberta, Negroni Anna, Di Nardo Giovanni, Del Giudice Emanuela, Costanzo Manuela, Pierdomenico Maria, Rossi Paolo, and Cucchiara Salvatore , Gastroenterology, Volume 5, Number 140, p.S–491, (2011)

Alternative splicing of the cyclin D1 proto-oncogene is regulated by the RNA-binding protein Sam68, Paronetto, M.P., Cappellari M., Busà R., Pedrotti S., Vitali Roberta, Comstock C., Hyslop T., Knudsen K.E., and Sette C. , Cancer Research, Volume 70, Number 1, p.229-239, (2010)

Authors' reply to: Inhibition of immune responses by Dasatinib may account for its different effects on neuroblastoma between in vitro and in vivo, Vitali, Roberta, and Raschellà Giuseppe , International Journal of Cancer, Volume 127, Number 5, p.1250, (2010)

T1804 CEACAM6: A Possible Role in Pediatric Crohn's Disease?, Costanzo, Manuela, Pierdomenico Maria, Stronati Laura, Negroni Anna, Vitali Roberta, Di Nardo Giovanni, Oliva Salvatore, Aloi Marina, and Cucchiara Salvatore , Gastroenterology, Volume 5, Number 138, p.S–582, (2010)

Activity of tyrosine kinase inhibitor Dasatinib in neuroblastoma cells in vitro and in orthotopic mouse model., Vitali, Roberta, Mancini Camillo, Cesi Vincenzo, Tanno Barbara, Piscitelli Marta, Mancuso Mariateresa, Sesti Fabiola, Pasquali Emanuela, Calabretta Bruno, Dominici Carlo, et al. , Int J Cancer, 2009 Dec 01, Volume 125, Issue 11, Number 11, p.2547-55, (2009)

Activation of p53-dependent responses in tumor cells treated with a PARC-interacting peptide, Vitali, Roberta, Cesi Vincenzo, Tanno Barbara, Ferrari-Amorotti G., Dominici C., Calabretta B., and Raschellà Giuseppe , Biochemical and Biophysical Research Communications, Volume 368, Number 2, p.350-356, (2008)

Clinical significance of CXC chemokine receptor-4 and c-Met in childhood rhabdomyosarcoma, Diomedi-Camassei, F., McDowell H.P., De loris M.A., Uccini S., Altavista P., Raschellà G., Vitali Roberta, Mannarino O., De Sio L., Cozzi D.A., et al. , Clinical Cancer Research, Volume 14, Number 13, p.4119-4127, (2008)

Slug (SNAI2) down-regulation by interference facilitates apoptosis and inhibits invasive growth in neuroblastoma preclinical models, Vitali, Roberta, Mancini C., Cesi Vincenzo, Tanno Barbara, Mancuso Mariateresa, Bossi G., Zhang Y., Martinez R.V., Calabretta B., Dominici C., et al. , Clinical Cancer Research, Volume 14, Number 14, p.4622-4630, (2008)

Bim-dependent apoptosis follows IGFBP-5 down-regulation in neuroblastoma cells., Tanno, Barbara, Vitali Roberta, De Arcangelis Davide, Mancini Camillo, Eleuteri Patrizia, Dominici Carlo, and Raschellà Giuseppe , Biochem Biophys Res Commun, 2006 Dec 15, Volume 351, Issue 2, Number 2, p.547-52, (2006)

Down-regulation of insulin-like growth factor I receptor activity by NVP-AEW541 has an antitumor effect on neuroblastoma cells in vitro and in vivo, Tanno, Barbara, Mancini C., Vitali Roberta, Mancuso Mariateresa, McDowell H.P., Dominici C., and Raschellà G. , Clinical Cancer Research, Volume 12, Number 22, p.6772-6780, (2006)

C/EBP α and β mimic retinoic acid activation of IGFBP-5 in neuroblastoma cells by a mechanism independent from binding to their site, Cesi, Vincenzo, Giuffrida M.L., Vitali Roberta, Tanno Barbara, Mancini C., Calabretta B., and Raschellà Giuseppe , Experimental Cell Research, Volume 305, Number 1, p.179-189, (2005)

Clinical and molecular evidence for c-kit receptor as a therapeutic target in neuroblastic tumors, Uccini, S., Mannarino O., McDowell H.P., Pauser U., Vitali Roberta, Natali P.G., Altavista P., Andreano T., Coco S., Boldrini R., et al. , Clinical Cancer Research, Volume 11, Number 1, p.380-389, (2005)

Silencing of endogenous IGFBP-5 by micro RNA interference affects proliferation, apoptosis and differentiation of neuroblastoma cells, Tanno, Barbara, Cesi Vincenzo, Vitali Roberta, Sesti F., Giuffrida M.L., Mancini C., Calabretta B., and Raschellà G. , Cell Death and Differentiation, Volume 12, Number 3, p.213-223, (2005)

Insulin-like growth factor binding protein 5: Contribution to growth and differentiation of neuroblastoma cells, Cesi, Vincenzo, Vitali Roberta, Tanno Barbara, Giuffrida M.L., Sesti F., Mancini C., and Raschellà G. , Annals of the New York Academy of Sciences, Volume 1028, p.59-68, (2004)

c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571, Vitali, Roberta, Cesi Vincenzo, Nicotra M.R., McDowell H.P., Donfrancesco A., Mannarino O., Natali P.G., Raschellà G., and Dominici C. , International Journal of Cancer, Volume 106, Number 2, p.147-152, (2003)

Cyclin D1-dependent regulation of B-myb activity in early stages of neuroblastoma differentiation, Cesi, Vincenzo, Tanno Barbara, Vitali Roberta, Mancini C., Giuffrida M.L., Calabretta B., and Raschellà Giuseppe , Cell Death and Differentiation, Volume 9, Number 11, p.1232-1239, (2002)